@lykhaque

Hepatologist & Addiction Medicine Physician @YaleDigestive @YaleADM

 New Haven, CT
Joined November 2013
  • Tweets210
  • Following401
  • Followers313
22Media
Very exciting to see Addiction Medicine for Liver Care Providers released this week! Was a pleasure working with colleagues on the AASLD Online Learning Committee to organize this CME-eligible course taught by Addiction Medicine leaders in the field, free for all AASLD members.
AASLD
@AASLDtweets27 Jan 2022
Liver Learning: Addiction Medicine for Liver Care Providers. The purpose of this course is to provide a focused overview of key addiction medicine topics and how they relate to the care of patients with chronic liver disease. Register here: bit.ly/3Av97zJ
2
10
1
44
Congratulations to ⭐ @YaleIMed @TradIMYale resident Dr. Maitri Patel on presenting her poster at #DDW2026! @YaleMed @YaleDigestive @AmerGastroAssn
4
125
Lamia Haque retweeted
AASLD
@AASLDtweets21 Nov 2025
Organized by Dr. Juan Pablo Arab on behalf of AASLD and ALEH, distinguished experts will discuss the latest advances in #ALD and #MetALD in their upcoming webinar with an open Q&A panel. A must-attend session for hepatology professionals with simultaneous interpretation available (English ↔ Spanish). bit.ly/49E22Ax
5
3
11
5,337
So proud to see 🌟 Yale medical student Dylan Balter present her work on clinician perspectives on addiction treatment across the continuum of transplant care at #TLM2025 before she jets off to @AMERSA_tweets - Congratulations!! @YaleDigestive @YaleADM @AASLDtweets @BalterDylan
1
2
11
799
Excited to be a part of this workshop on alcohol use disorder & alcohol-associated liver disease @ the Research Society on Alcohol Scientific Meeting along side @l_suthat @lykhaque @singal_ashwani (& Jessica Mellinger)! 📍Please join us in NOLA 📆 June 22, 9:15 am - 1:15 pm
3
20
882
Looking forward to hearing about AUD and liver transplantation from our esteemed panelists! All are welcome on May 21 at 12pm EDT, please see below to register and feel free to reach out with any questions!
AASLD
@AASLDtweets12 May 2025
📅 Join us May 21 for a PCSS-MAUD Panel Discussion. This webinar explores the medical, ethical, and social challenges faced by healthcare professionals, patients, and policy makers in determining eligibility managing post-transplant care. Register today: bit.ly/434FR1o
1
4
6
848
@PCSSMAUD @AASLDtweets @YaleADM @juanpabloarab @ASAMorg
1
2
275
Grateful to CLD for highlighting this important area and to leaders in the field for sharing expertise - from the neurobiology of addiction to AUD, OUD, tobacco and cannabis, to DILI, integrated HCV care and transplantation, recommend checking out this unique series.
ClinicalLiverDisease@CLD_Learning3 Jul 2024
Addictive disorders are increasingly impacting liver disease outcomes J Mellinger @lykhaque edit this crucial CLD series on addiction and liver disease. A must read! Full series: journals.lww.com/cld/pages/c… Sample content: journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex…
1
8
1,244
Hot off the presses, @lykhaque & Lorenzo Leggio review the role of AUD care in alcohol-associated liver disease treatment, effects on liver-related outcomes, impact of co-morbidities, & the current landscape of integrated & collaborative care. journals.lww.com/hep/abstrac…
1
1
6
354
Out @AGA_Gastro & @AGA_CGH -Promoting Prognostic Understanding and Health Equity for Patients With Advanced Liver Disease: Using “Best Case/Worst Case”. A true labor of love for a framework to improve GOC communication in hepatology #palliativehepatology bit.ly/3j6q8Ma
13
37
13
139
54,304
Our paper on the safety of inpatient health care is out in NEJM! Work was sponsored by @CRICO and done by a large and talented team. nejm.org/doi/full/10.1056/NE…

The Safety of Inpatient Health Care | NEJM

Adverse events during hospitalization are a major cause of patient harm, as documented in the 1991 Harvard Medical Practice Study. Patient safety has changed substantially in the decades since that...

nejm.org
2
21
5
59
23,606
Greatly appreciate 🙏 the opportunity to share our work @LTxJournal! @HopkinsGIHep @AndrewMCameron @G_Chander_GIM
Liver Transplantation Journal (LTxJournal)@LTxJournal7 Jan 2023
Patient reflections, challenges & supports related to early LT for severe alcohol-associated liver disease This qualitative study illuminates facets of ELT experiences relevant to future research studies on support interventions & ethical decision-making journals.lww.com/lt/Abstract…
2
7
19
3,194
Just casually watching the news last night and who do I see @Lorenzo__Leggio and Dr. Koob @NIAAAnews NIH researching drugs to reduce alcohol cravings nbcnews.com/nightly-news/vid… via @nbcnews

NIH researching drugs to reduce alcohol cravings

The National Institutes of Health is researching drugs to help with alcohol use disorder as excessive drinking is up more than twenty percent during the pandemic. NBC News’ Kate Snow reports from a...

nbcnews.com
2
5
23
2,179
⭐️Navigating the road to liver transplantation #equity⭐️ 🛑Many barriers along the LT cascade 💡We can and MUST implement actions and policies to address disparities! #DrLornaDove and I outline the disparities and provide an action plan! #LiverTwitter journals.lww.com/lt/Citation…
6
21
52
11,151
Lamia Haque retweeted
NEJM
@NEJM28 Dec 2022
Alcohol use disorder is a major cause of advanced liver disease worldwide. Bataller and colleagues review the epidemiology, pathophysiology, and treatment of alcohol-associated hepatitis including the evidence for steroids and liver transplantation. nej.md/3FO77Wk
12
433
21
1,199
314,511
"There are treatment gaps for individuals w/ co-occurring HCV & AUD" that need to be addressed, says @lykhaque. “For patients w/ HCV & AUD, this refers to a gap not only in AUD treatment, but also in lifesaving HCV treatment. Both are crucial for liver health.” @YaleIMed @YaleMed
NIH
@NIH14 Dec 2022
News: NIH-funded study finds hepatitis C treatment gap for individuals with alcohol use disorder dlvr.it/SfMQrB

NIH-funded study finds hepatitis C treatment gap for individuals with alcohol use disorder

People with AUD are less likely to receive antivirals.

nih.gov
3
1
11
A new study published in @JAMANetworkOpen suggests there are significant inequities in accessing direct-acting antivirals (DAAs) for hepatitis C treatment, a potentially lifesaving treatment. Read more. @YaleMed @YaleDigestive @YaleADM @lykhaque medicine.yale.edu/news-artic…

Patients With Alcohol Use Disorder Face Barriers to Lifesaving Hepatitis C Treatment, Study Finds

A Yale study finds that health providers have been slower to prescribe potentially lifesaving medications for hepatitis C when patients suffer from alcohol use

medicine.yale.edu
3
8
2,347
Glad to see our study, 'Association Between Alcohol Use Disorder and Direct-Acting Antiviral HCV Treatment,' published - patients with AUD are less likely to receive DAAs despite guidelines - ja.ma/3v9SA2e via @JAMANetworkOpen part of @JAMANetwork.
8
16
59
9,989
This held true regardless of self-reported abstinence by AUDIT-C results. In addition, there are concerning inequities in DAA receipt for racial/ethnic minoritized patients and for those with drug use disorders and psychiatric conditions.
1
2
163
There have been many successes in HCV treatment and more needs to be done to ensure equitable access for all and to integrate AUD and liver care. Grateful to my outstanding mentors and collaborators on this work @YaleADM @YaleDigestive @YaleIMed @YaleSPH and beyond.
3
143
Load more